Article Text

Download PDFPDF

1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas
  1. Pravesh Gupta1,
  2. Minghao Dang1,
  3. Dapeng Hao1,
  4. Krishna Bojja1,
  5. Tuan Tran1,
  6. Huma Shehwana1,
  7. Carlos Kamiya-Matsuoka1,
  8. Jianzhuo Li1,
  9. Alessandra Audia1,
  10. Cynthia Kassab1,
  11. Martina Ott1,
  12. Joy Gumin1,
  13. Sanaalarab Alenazy1,
  14. Alicia Goldman2,
  15. Sameer Seth2,
  16. Atul Maheshwari2,
  17. Veerakumar Balasubramaniyan1,
  18. Brian Vaillant3,
  19. John de Groot1,
  20. Antonio Lavarone4,
  21. Frederick Lang1,
  22. Nicholas Navin1,
  23. Amy Heimberger5,
  24. Linghua Wang1 and
  25. Krishna Bhat1
  1. 1University of Texas MD Anderson Cancer Center, Houston, TX, United States
  2. 2Baylor College of Medicine, Houston, TX, United States
  3. 3The University of Austin, Austin, TX, United States
  4. 4Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, United States
  5. 5Feinberg School of Medicine, Northwestern University, Chicago, IL, United States


Background Gliomas are recalcitrant brain tumors. Anti-glioma immunity and immunopathogenic responses are critical contributors for better survival of isocitrate dehydrogenase-mutant (IDHmut) over wild-type (IDHwt) gliomas. Despite this correlative pattern of immunity and survival, an unbiased understanding of cell-type specific transcriptomic and epigenomic states of glioma-derived myeloid cells beyond immunosuppressive paradigms remains elusive.

Methods To this end, we performed single-cell RNA-sequencing (scRNA-seq) on 140,000 tumor-associated immune cells from eighteen IDH mutation classified primary (N=8) and recurrent (N=10) human gliomas and three non-glioma brains (NGBs). We performed unsupervised clustering and cell annotation based on overlapping canonical lineage and signal dependent transcription factors. Gene ontology and gene set enrichment analyses were performed to define functional states of glioma associated myeloid cells.

Results Our analyses revealed twelve myeloid cell types across glioma subgroups. We noted abundant microglial cells in IDHmut than IDHwt gliomas. Concomitantly, continnum of microglia and macrophage phenotypes were observed in IDHwt glioma, which exhibit more severe tumor pathologies. Strikingly, we identified a hybrid microglia/macrophage cell subset with enriched interferon module inferred from our gene ontology analyses. These hybrid phagocytes were significantly increased in recurrent IDHwt gliomas. As tissue macrophages exhibit multifaceted polarization in response to microenvironmental cues, we clarify the existence of microglia/macrophage functional states beyond M1/M2 paradigms exemplified by the presence of palmitic-, oleic- acid, and glucocorticoid responsive polarized states. Specifically, certain microglia and monocyte-derived subpopulations were associated with antigen presentation gene modules, akin to cross-presenting dendritic cells. Furthermore, immune related gene ontology analysis identified enriched antigen presentation and phagocytosis gene modules in distinct microglia-like clusters. Importantly, the phagocytic immunomodulator; Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) was upregulated in these microglia-like cells. Contrary to tumor promoting role of TREM2 myeloid cells in non-brain cancers, we identify TREM2 axis as a regulator of antigen presentation. Additionally, single cell- Assay for Transposase-Accessible Chromatin using sequencing (sc-ATAC-seq) on ~40,000 tumor-associated microglia revealed genes associated with IFN-gamma/IL-12/IL-10 pathway were negatively regulated in IDHmut/IDHwt microglia compared to homeostatic microglia in NGBs.

Conclusions In summary, our study sculpts transcriptional and epigenomic details and re-defines glioma-specific immune contexture for downstream immunogenomics applications. We specifically reveal interferon and TREM2 nodes on microglia-like phagocytic cells as clinically tractable anti-glioma immunotherapy target.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.